Related Experiment Video
Updated: May 20, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Relating human genetic variation to variation in drug responses
Ashraf G Madian1, Heather E Wheeler, Richard Baker Jones
1Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA.
Trends in Genetics : TIG
|July 31, 2012
Summary
Pharmacogenomics uses genetic information to tailor drug treatments, improving efficacy and reducing toxicity. This field has advanced from single-gene studies to genome-wide analyses for personalized medicine.
Area of Science:
- Genomics
- Pharmacology
- Personalized Medicine
Background:
- Human genome sequencing has advanced significantly, with over 1000 genomes now available.
- Personalized medicine aims to tailor treatments to individual genetic profiles.
- Patient variability in drug response is a key challenge in clinical practice.
Purpose of the Study:
- To summarize the current state of pharmacogenomics.
- To highlight the evolution of pharmacogenomic research from candidate genes to genome-wide studies.
- To discuss challenges in translating pharmacogenomic data into clinical applications.
Main Methods:
- Review of current pharmacogenomic research.
- Analysis of the progression from single-gene to genome-wide approaches.
- Discussion of challenges in systems-level integration of genetic data and drug physiology.
Main Results:
- Pharmacogenomics has evolved from single-gene studies to comprehensive genome-wide analyses.
- The field is crucial for understanding patient-to-patient variation in drug response.
- Significant progress has been made in identifying genetic contributors to drug efficacy and toxicity.
Conclusions:
- Translating genomic information into personalized treatment strategies is the next frontier.
- Overcoming challenges in systems-level understanding is vital for effective personalized medicine.
- The ultimate goal is to develop more effective and safer clinical treatment strategies based on individual genetics.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...